Chimeric Antigen Receptor-Modified T Cells Redirected to EphA2 for the Immunotherapy of Non-Small Cell Lung Cancer.

Name: Chimeric Antigen Receptor-Modified T Cells Redirected to EphA2 for the Immunotherapy of Non-Small Cell Lung Cancer.
Author: Li, Ning

Chimeric Antigen Receptor-Modified T Cells Redirected to EphA2 for the Immunotherapy of Non-Small Cell Lung Cancer. — المؤلف: Li, Ning — Translational oncology Feb 2018

المؤلف: Li, Ning
النشر: Translational oncology Feb 2018
الوصف: 11-17 p.